Jim Cramer's Mad Money Stock Recap June 5th
CEO Interview: Ivan Seidenberg, Verizon (NYSE: VZ ), AT&T (NYSE: T)
Although everyone is talking about Apple's iPhone , Cramer says Verizon's CEO Ivan Seidenberg is "money," and predicts VZ will be able to hold its own against rival AT & T amid iPhone hype. Seidenberg commented Verizon has "the most advanced network" and a full range of new products, including handsets for music downloads and mobile TV products. After the buzz surrounding the iPhone dies down, customers will want "flexibility and breadth of choice," added Seidenberg. He said the company is concentrating on getting its stock up, and has seen substantial success in its wireless and fiber optic units. When Cramer asked if VZ would buy a TV network, Seidenberg responded he would "never say never" but added the company doesn't need to make such a purchase.
Idyllic Drugs: Acadia Pharmaceuticals (NasdaqGM: ACAD)
Cramer says it is time to buy this speculative drug stock, which is coming out with two drugs for schizophrenia and one for Parkinson's. While Cramer does not recommend buying ACAD on strength of its products but on the data that will come out, he adds, "If any of these drugs pan out, you have struck gold." He would invest in the company before its drugs are approved. One schizophrenia drug's Phase II results should bring the stock higher, success for the Parkinson's drug will make it a $709-million-a-year drug, and Acadia's ACP-104 is perhaps the strongest. "It's bottoming now in anticipation of the forthcoming data. I want you in for the ride up. This is a trade, not an investment," Cramer advised.
A Real Steel: Barnes Group (NYSE: B)
Cramer says this metals company is a "steal" and should benefit from the aerospace sector which is "running hot" and trucking, which is healthy, based on Cummins numbers. While Cramer admits he missed the company's bottom, this "under the radar" stock should have more upside as it attracts attention and more coverage from analysts.
Published By SeekingAlpha
Although everyone is talking about Apple's iPhone , Cramer says Verizon's CEO Ivan Seidenberg is "money," and predicts VZ will be able to hold its own against rival AT & T amid iPhone hype. Seidenberg commented Verizon has "the most advanced network" and a full range of new products, including handsets for music downloads and mobile TV products. After the buzz surrounding the iPhone dies down, customers will want "flexibility and breadth of choice," added Seidenberg. He said the company is concentrating on getting its stock up, and has seen substantial success in its wireless and fiber optic units. When Cramer asked if VZ would buy a TV network, Seidenberg responded he would "never say never" but added the company doesn't need to make such a purchase.
Idyllic Drugs: Acadia Pharmaceuticals (NasdaqGM: ACAD)
Cramer says it is time to buy this speculative drug stock, which is coming out with two drugs for schizophrenia and one for Parkinson's. While Cramer does not recommend buying ACAD on strength of its products but on the data that will come out, he adds, "If any of these drugs pan out, you have struck gold." He would invest in the company before its drugs are approved. One schizophrenia drug's Phase II results should bring the stock higher, success for the Parkinson's drug will make it a $709-million-a-year drug, and Acadia's ACP-104 is perhaps the strongest. "It's bottoming now in anticipation of the forthcoming data. I want you in for the ride up. This is a trade, not an investment," Cramer advised.
A Real Steel: Barnes Group (NYSE: B)
Cramer says this metals company is a "steal" and should benefit from the aerospace sector which is "running hot" and trucking, which is healthy, based on Cummins numbers. While Cramer admits he missed the company's bottom, this "under the radar" stock should have more upside as it attracts attention and more coverage from analysts.
Published By SeekingAlpha
posted by Stock Administrator @ 7:29 AM
0 Comments:
Post a Comment
<< Home